Detalhe da pesquisa
1.
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.
N Engl J Med
; 384(3): 238-251, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33332778
2.
Leveraging opportunities for treatment/user simplicity (LOTUS): Navigating the current treatment landscape for achieving hepatitis C virus elimination among persons who inject drugs.
J Viral Hepat
; 31(6): 342-356, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38433561
3.
Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD-related cirrhosis.
Hepatology
; 77(2): 546-557, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35809234
4.
Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat.
Clin Gastroenterol Hepatol
; 21(1): 143-152.e3, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34999207
5.
Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial.
J Hepatol
; 77(3): 607-618, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35439567
6.
Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis.
Gastroenterology
; 160(1): 219-231.e1, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32781086
7.
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH.
Hepatology
; 73(2): 625-643, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33169409
8.
Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease.
Am J Gastroenterol
; 116(12): 2399-2409, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34382947
9.
Role of Ocular Ultrasonography to Distinguish Papilledema From Pseudopapilledema.
J Neuroophthalmol
; 41(2): 206-211, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33296160
10.
Utility of Spectral-Domain Optical Coherence Tomography in Differentiating Papilledema From Pseudopapilledema: A Prospective Longitudinal Study.
J Neuroophthalmol
; 41(4): e509-e515, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32956225
11.
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials.
J Hepatol
; 73(1): 26-39, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32147362
12.
Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials.
Hepatology
; 70(5): 1521-1530, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31271665
13.
CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients.
Liver Int
; 39(11): 2082-2093, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31402538
14.
Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens.
Clin Infect Dis
; 62(3): 280-288, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26521268
15.
Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti-Hepatitis C Virus Therapy in Patients With Advanced Liver Disease.
Clin Infect Dis
; 62(4): 440-447, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26503379
16.
Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study.
Lancet
; 385(9973): 1107-13, 2015 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25591505
17.
Maintaining Patient Safety and Data Integrity of Nonalcoholic Steatohepatitis Clinical Trials During the Severe Acute Respiratory Syndrome-Coronavirus 2 Pandemic.
Hepatology
; 72(5): 1509-1513, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32794597
18.
Photopsias in the Setting of Nivolumab Therapy.
J Neuroophthalmol
; 41(1): e25-e26, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32108668
19.
Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection: An Open-Label, Nonrandomized Trial.
Ann Intern Med
; 163(12): 899-907, 2015 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26595450
20.
Utility of hepatitis C viral load monitoring on direct-acting antiviral therapy.
Clin Infect Dis
; 60(12): 1743-51, 2015 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25733369